Citadel Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-51,575
| Closed | -$2.61M | – | 5874 |
|
|
2020
Q3 | $2.61M | Buy |
51,575
+13,347
| +35% | +$674K | ﹤0.01% | 2030 |
|
|
2020
Q2 | $1.82M | Buy |
38,228
+31,254
| +448% | +$1.49M | ﹤0.01% | 2337 |
|
|
2020
Q1 | $342K | Sell |
6,974
-5,976
| -46% | -$293K | ﹤0.01% | 3687 |
|
|
2019
Q4 | $743K | Buy |
+12,950
| New | +$743K | ﹤0.01% | 3260 |
|
|
2018
Q3 | – | Sell |
-42,960
| Closed | -$874K | – | 4913 |
|
|
2018
Q2 | $874K | Buy |
+42,960
| New | +$874K | ﹤0.01% | 2769 |
|